A citation-based method for searching scientific literature

Maryam Akhoundi, Mahsa Mohammadi, Seyedeh Saeideh Sahraei, Mohsen Sheykhhasan, Nashmin Fayazi. Cell Oncol (Dordr) 2021
Times Cited: 2







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity




Association of insulin and insulin-like growth factors with Barrett's oesophagus.
Katarina B Greer, Cheryl L Thompson, Lacie Brenner, Beth Bednarchik, Dawn Dawson, Joseph Willis, William M Grady, Gary W Falk, Gregory S Cooper, Li Li,[...]. Gut 2012
53
50

Function of p21 and its therapeutic effects in esophageal cancer.
Lei Wang, Huiqiong Han, Lin Dong, Zehua Wang, Yanru Qin. Oncol Lett 2021
1
100


Ramucirumab and durvalumab for previously treated, advanced non-small-cell lung cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular carcinoma: An open-label, phase Ia/b study (JVDJ).
Yung-Jue Bang, Talia Golan, Laetitia Dahan, Siqing Fu, Victor Moreno, Keunchil Park, Ravit Geva, Filippo De Braud, Zev A Wainberg, Martin Reck,[...]. Eur J Cancer 2020
25
50

Increased photodynamic therapy sensitization in tumors using a nitric oxide-based nanoplatform with ATP-production blocking capability.
Qinyanqiu Xiang, Bin Qiao, Yuanli Luo, Jin Cao, Kui Fan, Xinghua Hu, Lan Hao, Yang Cao, Qunxia Zhang, Zhigang Wang. Theranostics 2021
6
50

Esophageal Microenvironment: From Precursor Microenvironment to Premetastatic Niche.
Peng Han, Peng Cao, Shan Hu, Kangle Kong, Yu Deng, Bo Zhao, Fan Li. Cancer Manag Res 2020
5
50

A phase II and pharmacodynamic study of sunitinib in relapsed/refractory oesophageal and gastro-oesophageal cancers.
C Wu, S Mikhail, L Wei, C Timmers, S Tahiri, A Neal, J Walker, S El-Dika, M Blazer, J Rock,[...]. Br J Cancer 2015
6
50

Cancer-associated fibroblasts (CAFs) promote the lymph node metastasis of esophageal squamous cell carcinoma.
Hajime Kashima, Kazuhiro Noma, Toshiaki Ohara, Takuya Kato, Yuki Katsura, Satoshi Komoto, Hiroaki Sato, Ryoichi Katsube, Takayuki Ninomiya, Hiroshi Tazawa,[...]. Int J Cancer 2019
35
50


Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma.
Shinya Ohashi, Shin'ichi Miyamoto, Osamu Kikuchi, Tomoyuki Goto, Yusuke Amanuma, Manabu Muto. Gastroenterology 2015
289
50

Rapid decrease in delivery of chemotherapy to tumors after anti-VEGF therapy: implications for scheduling of anti-angiogenic drugs.
Astrid A M Van der Veldt, Mark Lubberink, Idris Bahce, Maudy Walraven, Michiel P de Boer, Henri N J M Greuter, N Harry Hendrikse, Jonas Eriksson, Albert D Windhorst, Pieter E Postmus,[...]. Cancer Cell 2012
237
50

Effects of diphyllin as a novel V-ATPase inhibitor on TE-1 and ECA-109 cells.
Haijiao Chen, Pengfei Liu, Ting Zhang, Yi Gao, Yingdi Zhang, Xiuyun Shen, Xiao Li, Weidong Shen. Oncol Rep 2018
14
50

Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study.
Ghassan K Abou-Alfa, Vaibhav Sahai, Antoine Hollebecque, Gina Vaccaro, Davide Melisi, Raed Al-Rajabi, Andrew S Paulson, Mitesh J Borad, David Gallinson, Adrian G Murphy,[...]. Lancet Oncol 2020
283
50

A Novel Systemic Inflammatory Score Combined With Immunoinflammatory Markers Accurately Reflects Prognosis in Patients With Esophageal Cancer.
Takafumi Suzuki, Yusuke Ishibashi, Hironori Tsujimoto, Shinsuke Nomura, Keita Kouzu, Yujiro Itazaki, Takao Sugihara, Manabu Harada, Nozomi Ito, Hidekazu Sugasawa,[...]. In Vivo 2020
2
50

The tumor microenvironment in esophageal cancer.
E W Lin, T A Karakasheva, P D Hicks, A J Bass, A K Rustgi. Oncogene 2016
148
50

Correlation of hypoxia status with radiosensitizing effects of sodium glycididazole: A preclinical study.
Yang Yu, Xiaolin Li, Hengwei Xu, Jing Liu, Min Dong, Jia Yang, Lu Sun, Xiaorong Sun, Ligang Xing. Oncol Lett 2018
5
50

VEGF receptor signalling - in control of vascular function.
Anna-Karin Olsson, Anna Dimberg, Johan Kreuger, Lena Claesson-Welsh. Nat Rev Mol Cell Biol 2006
50

Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia.
David H Wang, Nicholas J Clemons, Tomoharu Miyashita, Adam J Dupuy, Wei Zhang, Anette Szczepny, Ian M Corcoran-Schwartz, Daniel L Wilburn, Elizabeth A Montgomery, Jean S Wang,[...]. Gastroenterology 2010
128
50

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma.
Robert H I Andtbacka, Howard L Kaufman, Frances Collichio, Thomas Amatruda, Neil Senzer, Jason Chesney, Keith A Delman, Lynn E Spitler, Igor Puzanov, Sanjiv S Agarwala,[...]. J Clin Oncol 2015
50

Identification of the Prognostic Value of Immune-Related Genes in Esophageal Cancer.
Xiong Guo, Yujun Wang, Han Zhang, Chuan Qin, Anqi Cheng, Jianjun Liu, Xinglong Dai, Ziwei Wang. Front Genet 2020
9
50

Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours.
Robin L Jones, Mark J Ratain, Peter J O'Dwyer, Lillian L Siu, Jacek Jassem, Jacques Medioni, Maja DeJonge, Charles Rudin, Michael Sawyer, David Khayat,[...]. Eur J Cancer 2019
11
50


A Novel Strategy through Combining iRGD Peptide with Tumor-Microenvironment-Responsive and Multistage Nanoparticles for Deep Tumor Penetration.
Xingli Cun, Jiantao Chen, Shaobo Ruan, Li Zhang, Jingyu Wan, Qin He, Huile Gao. ACS Appl Mater Interfaces 2015
67
50

Lysyl oxidase impacts disease outcomes and correlates with global DNA hypomethylation in esophageal cancer.
Rebecca Kalikawe, Yoshifumi Baba, Daichi Nomoto, Kazuo Okadome, Keisuke Miyake, Kojiro Eto, Yukiharu Hiyoshi, Youhei Nagai, Masaaki Iwatsuki, Takatsugu Ishimoto,[...]. Cancer Sci 2019
7
50


Esophageal cancer.
Peter C Enzinger, Robert J Mayer. N Engl J Med 2003
50

Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointestinal carcinomas.
N Sadanaga, H Nagashima, K Mashino, K Tahara, H Yamaguchi, M Ohta, T Fujie, F Tanaka, H Inoue, K Takesako,[...]. Clin Cancer Res 2001
158
50


Sunitinib plus paclitaxel in patients with advanced esophageal cancer: a phase II study from the Hoosier Oncology Group.
Jordan M Schmitt, Scott R Sommers, William Fisher, Rafat Ansari, Erwin Robin, Karuna Koneru, John McClean, Ziyue Liu, Yan Tong, Nasser Hanna. J Thorac Oncol 2012
19
50

Safety, Activity, and Biomarkers of SHR-1210, an Anti-PD-1 Antibody, for Patients with Advanced Esophageal Carcinoma.
Jing Huang, Binghe Xu, Hongnan Mo, Weilong Zhang, Xuelian Chen, Dawei Wu, Dong Qu, Xingyuan Wang, Bo Lan, Beibei Yang,[...]. Clin Cancer Res 2018
78
50

The Combination Options and Predictive Biomarkers of PD-1/PD-L1 Inhibitors in Esophageal Cancer.
Hui Yang, Kunlun Wang, Tao Wang, Mengxi Li, Bingxu Li, Shenglei Li, Ling Yuan. Front Oncol 2020
12
50

HIF-1α pathway: role, regulation and intervention for cancer therapy.
Georgina N Masoud, Wei Li. Acta Pharm Sin B 2015
743
50



Dihydroartemisinin Increases the Sensitivity of Photodynamic Therapy Via NF-κB/HIF-1α/VEGF Pathway in Esophageal Cancer Cell in vitro and in vivo.
Yanjing Li, Hong Sui, Cailing Jiang, Shumin Li, Yu Han, Peng Huang, Xiaoxue Du, Jingwen Du, Yuxian Bai. Cell Physiol Biochem 2018
25
50

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.
Tracy T Batchelor, A Gregory Sorensen, Emmanuelle di Tomaso, Wei-Ting Zhang, Dan G Duda, Kenneth S Cohen, Kevin R Kozak, Daniel P Cahill, Poe-Jou Chen, Mingwang Zhu,[...]. Cancer Cell 2007
50

Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus.
Reginald V N Lord, Ji Min Park, Kumari Wickramasinghe, Steven R DeMeester, Stefan Oberg, Dennis Salonga, Jon Singer, Jeffrey H Peters, Kathleen D Danenberg, Tom R Demeester,[...]. J Thorac Cardiovasc Surg 2003
57
50

Clinical significance of CXCL-8/CXCR-2 network in esophageal squamous cell carcinoma.
Masaharu Ogura, Hiroya Takeuchi, Hirofumi Kawakubo, Tomohiko Nishi, Kazumasa Fukuda, Rieko Nakamura, Tsunehiro Takahashi, Norihito Wada, Yoshiro Saikawa, Tai Omori,[...]. Surgery 2013
48
50


Transforming growth factor-β signaling: Tumorigenesis and targeting for cancer therapy.
Amirhossein Ahmadi, Masoud Najafi, Bagher Farhood, Keywan Mortezaee. J Cell Physiol 2019
67
50

Increased IL-17-producing CD4(+) T cells in patients with esophageal cancer.
Deyu Chen, Qin Hu, Chaoming Mao, Zhijun Jiao, Shengjun Wang, Lichao Yu, Ying Xu, Dongfang Dai, Lijia Yin, Huaxi Xu. Cell Immunol 2012
31
50

Estimating Individualized Absolute Risk for Esophageal Squamous Cell Carcinoma: A Population-Based Study in High-Risk Areas of China.
Yi Shen, Shuanghua Xie, Lei Zhao, Guohui Song, Yi Shao, Changqing Hao, Chen Niu, Xiaoli Ruan, Zhaoping Zang, Rena Nakyeyune,[...]. Front Oncol 2021
5
50

Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program.
Markus Moehler, Irina Gepfner-Tuma, Annett Maderer, Peter C Thuss-Patience, Joern Ruessel, Susanna Hegewisch-Becker, Hansjochen Wilke, Salah-Eddin Al-Batran, Mohammad-Reza Rafiyan, Florian Weißinger,[...]. BMC Cancer 2016
37
50

Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer.
Caroline Wigerup, Sven Påhlman, Daniel Bexell. Pharmacol Ther 2016
299
50

Inflammatory gradient in Barrett's oesophagus: implications for disease complications.
R C Fitzgerald, S Abdalla, B A Onwuegbusi, P Sirieix, I T Saeed, W R Burnham, M J G Farthing. Gut 2002
147
50

Integrin alpha 6: a novel therapeutic target in esophageal squamous cell carcinoma.
Junhye Kwon, Tae-Sup Lee, Hae Won Lee, Moon Chul Kang, Hyeon-Joon Yoon, Ji-Hee Kim, Jong Ho Park. Int J Oncol 2013
26
50


The Extracellular Matrix Modulates the Metastatic Journey.
FuiBoon Kai, Allison P Drain, Valerie M Weaver. Dev Cell 2019
107
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.